Bionethos Innovation GmbH owns more than 70 patents on proprietary molecules and their clinical application.
In order to advance further developments, the plant near Leipzig will be expanded in order to expand R&D activities in the future and to establish them as an essential part of the company structure.
Funded research projects of the company Bionethos Innovation GmbH
2019 – 2021
Identification of highly potent tissue-protective agents for medical applications
SAB Forschungsprojekt, Project Number 100355882
2015 – 2017
Development of a method for the treatment of osteoarthrosis of the dog by regeneration of the articular cartilage by stem cell activation.
ZIM Projekt, Project Number 16KN040229
2015 – 2016
Training network for developing innovative (bio)artificial devices for treatment of kidney and liver disease
7th Frame Programme – Marie Curie Initial Training Network INT; Project Number 316690
2014 – 2016
Endogenous activation of skin stem cells through the development of a pharmaceutically active wound gel
SAB Forschungsprojekt, Project Number 100176064
2013 – 2015
Implementation of the Bio-Bionic Principle of Regeneration from the Scientific to the Clinical Field
SAB Innovationsassistent, Project Number 100177876